MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$71,553K
Net Income
-$39,788K
Net Profit Margin
-55.61%
EPS
-$0.25
Unit: Thousand (K) dollars
Revenue Breakdown
Service
Revenue From Contract With Custo...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
71,553
70,874
71,681
93,973
Cost of revenue
20,165
18,708
18,224
18,157
Research and development
19,153
23,623
21,763
23,669
Sales and marketing
26,414
26,346
24,481
23,470
General and administrative
21,168
20,984
19,557
17,959
Amortization of intangible assets
423
419
429
428
Impairment of long-lived assets
-
-
0
0
Total operating expenses
87,323
90,080
84,454
83,683
Loss from operations
-15,770
-19,206
-12,773
10,290
Interest and other income, net
2,256
2,080
2,148
2,226
Interest expense
2,694
2,889
2,954
2,971
Loss on revenue interest liability extinguishment
23,733
-
-
-
Net loss
-39,941
-20,015
-13,579
9,545
Add net loss (income) attributable to noncontrolling interest
-153
18
0
-1
Net loss attributable to adaptive biotechnologies corporation
-39,788
-20,033
-13,579
9,546
Basic EPS
-0.25
-0.13
-0.089
0.06
Diluted EPS
-0.25
-0.13
-0.095
0.06
Basic Average Shares
159,855,257
155,521,048
153,178,137
152,432,307
Diluted Average Shares
159,855,257
155,521,048
142,448,337
163,162,107
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to adaptive...
-$39,788K
(-55.34%↓ Y/Y)
Add net loss
(income) attributable to...
-$153K
(-828.57%↓ Y/Y)
Service
$66,168K
(48.90%↑ Y/Y)
Revenue From Contract
With Customer...
$5,385K
Net loss
-$39,941K
(-56.06%↓ Y/Y)
Interest and other
income, net
$2,256K
(-5.65%↓ Y/Y)
MRDRevenue
$66,168K
(32.50%↑ Y/Y)
Immune Medicine
Revenue
$5,385K
(-39.77%↓ Y/Y)
Loss on revenue
interest liability...
$23,733K
Loss from operations
-$15,770K
(37.01%↑ Y/Y)
Interest expense
$2,694K
(-8.62%↓ Y/Y)
Revenue
$71,553K
(21.53%↑ Y/Y)
Total operating
expenses
$87,323K
(4.06%↑ Y/Y)
Sales and marketing
$26,414K
(12.05%↑ Y/Y)
General and
administrative
$21,168K
(19.01%↑ Y/Y)
Cost of revenue
$20,165K
(12.03%↑ Y/Y)
Research and development
$19,153K
(-20.64%↓ Y/Y)
Amortization of intangible
assets
$423K
(0.00%↑ Y/Y)
Buy us a coffee
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)